Users’ Perspectives, Opportunities, and Barriers of the Strengthen Your Ankle App for Evidence-Based Ankle Sprain Prevention: Mixed-Methods Process Evaluation for a Randomized Controlled Trial

doi:10.2196/rehab.8638

JMIR Publications

JMIR Rehabilitation and Assistive Technologies

Browse by Year:

Browse:
Issues
Authors
Themes

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.

JMIR Rehabilitation and Assistive Technologies

Published on 06.07.18 in Vol 5, No 2 (2018): Jul-Dec

This paper is in the following e-collection/theme issue:

Tweetations for "Users’ Perspectives, Opportunities, and Barriers of the Strengthen Your Ankle App for Evidence-Based Ankle Sprain Prevention: Mixed-Methods Process Evaluation for a Randomized Controlled Trial"

Miriam van Reijen, Marianne Asscheman, Ingrid Vriend, Willem van Mechelen, Evert Verhagen

JMIR Rehabil Assist Technol 2018 (Jul 06); 5(2):e13

Tweets 1 - 10 of 10.

Tweets 1 - 10 of 10. 1

JMIR Rehabilitation and Assistive Technologies

Citing this Article

Published on 06.07.18 in Vol 5, No 2 (2018): Jul-Dec

This paper is in the following e-collection/theme issue:

Tweetations for "Users’ Perspectives, Opportunities, and Barriers of the Strengthen Your Ankle App for Evidence-Based Ankle Sprain Prevention: Mixed-Methods Process Evaluation for a Randomized Controlled Trial"

Tweets 1 - 10 of 10.